Gregory M. Cresswell

TNF is a potential therapeutic target to suppress prostatic inflammation and hyperplasia in autoimmune disease

Renee E. Vickman, LaTayia Aaron-Brooks, Renyuan Zhang et al. · Nature Communications · 2022 · 77 citations · Full text

Sustained Delivery of Carfilzomib by Tannic Acid-Based Nanocapsules Helps Develop Antitumor Immunity

Maie S. Taha, Gregory M. Cresswell, Joonyoung Park et al. · Nano Letters · 2019 · 74 citations

Folate Receptor Beta Designates Immunosuppressive Tumor-Associated Myeloid Cells That Can Be Reprogrammed with Folate-Targeted Drugs

Gregory M. Cresswell, Bingbing Wang, Erin M. Kischuk et al. · Cancer Research · 2020 · 68 citations · Full text

Use of Folate-Conjugated Imaging Agents To Target Alternatively Activated Macrophages in a Murine Model of Asthma

Jiayin Shen, Venkatesh Chelvam, Gregory M. Cresswell et al. · Molecular Pharmaceutics · 2013 · 39 citations

Thrombin‐PAR1 signaling in pancreatic cancer promotes an immunosuppressive microenvironment

Patrick G. Schweickert, Yi Yang, Emily White et al. · Journal of Thrombosis and Haemostasis · 2020 · 38 citations · Full text